USP53 and breast carcinoma: The analysis from immunohistochemistry staining exhibited that the low expression of USP53 was associated with TNM stage of breast cancers, and more cases with III stage possessed lower USP53 level than those with I/II stages (Table 1; Fig. 2A and B).